Skip to main content

Other

Full read, comprehensive review of NLRP3 inflammasome & its role in inate immunity (eg, infections), but also lifestyle (obesity, diabetes, NAFLD, heart/lung disease, periodontitis) and autoimmune diseases https://t.co/rCk9ncEsGA https://t.co/qc9eSIAVYe
Dr. John Cush @RheumNow( View Tweet )
ICYMI: Community-Acquired Pneumonia (CAP) https://t.co/geb8y2AK26 https://t.co/cB3y5vQoz1
Dr. John Cush @RheumNow( View Tweet )
PMR - a Risk Factor for Recalcitrant Giant Cell Arteritis? Despite the clinical similarities and treatment differences between giant cell arteritis (GCA polymyalgia rheumatica (PMR), confusion exists regarding the impact of overlapping disorders. https://t.co/Slnq68YQgh https://t.co/nCYswGmlCk
Dr. John Cush @RheumNow( View Tweet )
EULAR 2024 Recommendations on Reproductive Health https://t.co/QuXQlpQv8O https://t.co/nHC7LOLLl8
Dr. John Cush @RheumNow( View Tweet )
ICYMI: Best Imaging in Giant Cell Arteritis - US, PET, MRI? https://t.co/J4aE4jxNb0 https://t.co/b6axwp4Tuw
Dr. John Cush @RheumNow( View Tweet )
ICYMI: 2023 EULAR Non-pharmacological Management of Hip and Knee Osteoarthritis: 2023 update https://t.co/iccSFuAogX https://t.co/ORzwvDKqVo
Dr. John Cush @RheumNow( View Tweet )
ICYMI: Hidradenitis Suppurativa-Related Autoinflammatory Syndromes https://t.co/46g8ek286u https://t.co/FEFq4vkiPk
Dr. John Cush @RheumNow( View Tweet )
Review of Amyloidosis The New England Journal of Medicine has published a review of systemic amyloidosis. https://t.co/qtbdPrlKnj https://t.co/wcqvRAauWC
Dr. John Cush @RheumNow( View Tweet )
RT @drdavidliew I have to say: upadacitinib looks very decent for GCA. Not a panacea, but it definitely does something & good safety during trial. Would love to eventually see: - H2H comparative effect vs toci, secukinumab - structural outcomes - long-term safety #EULAR2024

Dr. John Cush @RheumNow( View Tweet )

Review of Amyloidosis The New England Journal of Medicine has published a review of systemic amyloidosis. https://t.co/4507N4DwLk https://t.co/Q0MP5XXUHr
Dr. John Cush @RheumNow( View Tweet )
How do you manage new progressive ILD?

Dr. John Cush @RheumNow( View Tweet )

The Crossroads of Autoinflammation and Autoimmunity Dr. Andrea Fava shares his perspectives on autoinflammation and autoimmunity, a topic covered by many sessions at Eular 2024 in Vienna, Austria. https://t.co/7hJeTf3O6y https://t.co/V43YHjhEhn
Dr. John Cush @RheumNow( View Tweet )
Vilobelimab, an anticomplement factor 5a (C5a) antibody, shown in this case report to be effective in (difficult to treat) pyoderma gangrenosum. https://t.co/P241Knoco6 https://t.co/hrCxOv8SEA
Dr. John Cush @RheumNow( View Tweet )
Digital Rheumatology Dr. Jonathan Kay reviews abstracts POS0451 and POS0607 presented at Eular 2024 in Vienna, Austria. https://t.co/9twSiXYL3N https://t.co/9vz77SrVLt
Dr. John Cush @RheumNow( View Tweet )
Systematic review of Autoimmune Dz (AID) & myelodysplastic syndrome (MDS) finds AIDs found in 17.5% of MDS pts. With AID, MDS mortality rates ranged 15.3-67%. Why this relationship exists is unclear. https://t.co/SZNH8v2CIT https://t.co/QTGiqUCqqs
Dr. John Cush @RheumNow( View Tweet )
ChatGPT in Rheumatology and Qualitative Research Dr. Bella Mehta discusses abstract OP0158 presented at Eular 2024 in Vienna, Austria. https://t.co/2EGLJdK2Pl https://t.co/AaRFqyo6jq
Dr. John Cush @RheumNow( View Tweet )
Planetary Health in Rheumatology Dr. Antoni Chan interviews Dr. Nelly Ziade about her session Planetary Health, presented at Eular 2024 in Vienna, Austria. https://t.co/gBkwyO1dWQ https://t.co/VvGqwi6tlJ
Dr. John Cush @RheumNow( View Tweet )
Top 10 Drug companies (revenue) 10 Regeneron $12.2b 9 Vertex $8.9b 8 Amgen $26.3b 7 Gilead $27.3b 6 Lilly $28.5b 5 BMS $46.2b 4 Merck $59.3b 3 AbbVie $58.1b 2 J&J $94.9b 1 Pfizer $100.3b https://t.co/GNlGToGcb1 https://t.co/OWyVUBzeO6
Dr. John Cush @RheumNow( View Tweet )
JAMA: 3 prospective cohort studies in USA show that multivitamin use by 390 124 healthy adults did not alter mortality risk (HR, 1.04; 95% CI, 1.02-1.07) https://t.co/VDxrI5Bskw https://t.co/o9wdITR0UT
Dr. John Cush @RheumNow( View Tweet )

Low Back Pain? Take a Walk!

A randomised controlled trial of adults with recurrent low back pain (LBP) has shown that a program of progressive walking and education intervention significantly reduced low back pain recurrence.

Read Article
Artificial Intelligence: Detection of CPPD on Hand Radiographs Dr. Antoni Chan interviews Dr. Thomas Hugle about abstract OP0112 presented at Eular 2024 in Vienna, Austria. https://t.co/jQrwKXuaDc https://t.co/Ecv69wvHxA
Dr. John Cush @RheumNow( View Tweet )
EUSTAr study of 4431 systemic sclerosis (SSc) pts - anti-SSA antibodies are detected in 15% of SSc-patients and represent an independent risk factor for the presence of lung fibrosis (OR 1.24) & more severe lung involvement. #EULA2024 OP0013 https://t.co/oW6NBjIG7E https://t.co/toyvHxJlr9
Dr. John Cush @RheumNow( View Tweet )
Cognitive Function in Older Adults: Worse in Lupus Dr. Mrinalini Dey discusses abstract POS0730 presented at Eular 2024 in Vienna, Austria. https://t.co/zedGdNbHw4 https://t.co/DIHvkEZRVk
Dr. John Cush @RheumNow( View Tweet )
The Crossroads of Autoinflammation and Autoimmunity Dr. Andrea Fava shares his perspectives on autoinflammation and autoimmunity, a topic covered by many sessions at Eular 2024 in Vienna, Austria. https://t.co/PXdHTWqVsX https://t.co/VZbZBk3a9f
Dr. John Cush @RheumNow( View Tweet )